Concepedia

Megumi Nakanishi

MN

Statistics

Publications

14

Citations

618

H-Index

13

Active since

2004

Affiliations

Saitama Medical University(Current)

Taisho Pharmaceutical (Japan)

Keio University

University of Occupational and Environmental Health Japan

Kanazawa Medical University

Megumi Nakanishi is an author at Saitama Medical University specializing in life sciences, medicine, and inflammatory arthritis.

Publications per year

2004–2023

14

Publications

14

Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis

Jun‐ichi Satoh, Megumi Nakanishi, Fumiko Koike et al. · Neurobiology of Disease · 2005 · 132 citations

, , +16

Relevance of Distinct Monocyte Subsets to Clinical Course of Ischemic Stroke Patients

Muichi Kaito, Shinichi Araya, Yuichiro Gondo et al. · PLoS ONE · 2013 · 108 citations · Full text

, , +17

Phase II/III Results of a Trial of Anti–Tumor Necrosis Factor Multivalent NANOBODY Compound Ozoralizumab in Patients With Rheumatoid Arthritis

Tsutomu Takeuchi, Masafumi Kawanishi, Megumi Nakanishi et al. · Arthritis & Rheumatology · 2022 · 65 citations · Full text

, , +14

T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients

Jun‐ichi Satoh, Megumi Nakanishi, Fumiko Koike et al. · Journal of Neuroimmunology · 2006 · 55 citations

, , +16

Efficacy and safety of anti-TNF multivalent NANOBODY® compound ‘ozoralizumab’ without methotrexate co-administration in patients with active rheumatoid arthritis: A 52-week result of phase III, randomised, open-label trial (NATSUZORA trial)

Yoshiya Tanaka, Masafumi Kawanishi, Megumi Nakanishi et al. · Modern Rheumatology · 2022 · 43 citations · Full text

, , +15

1–5 of 14